184 related articles for article (PubMed ID: 15590419)
21. Differential expression of c-Met, its ligand HGF/SF and HER2/neu in DCIS and adjacent normal breast tissue.
Lindemann K; Resau J; Nährig J; Kort E; Leeser B; Annecke K; Welk A; Schäfer J; Vande Woude GF; Lengyel E; Harbeck N
Histopathology; 2007 Jul; 51(1):54-62. PubMed ID: 17593080
[TBL] [Abstract][Full Text] [Related]
22. Hepatocyte growth factor and c-Met immunoreactivity are associated with metastasis in high grade salivary gland carcinoma.
Tsukinoki K; Yasuda M; Mori Y; Asano S; Naito H; Ota Y; Osamura RY; Watanabe Y
Oncol Rep; 2004 Nov; 12(5):1017-21. PubMed ID: 15492787
[TBL] [Abstract][Full Text] [Related]
23. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy.
Li Y; Lal B; Kwon S; Fan X; Saldanha U; Reznik TE; Kuchner EB; Eberhart C; Laterra J; Abounader R
Cancer Res; 2005 Oct; 65(20):9355-62. PubMed ID: 16230398
[TBL] [Abstract][Full Text] [Related]
24. Immunoexpression of the hepatocyte growth factor (HGF), HGF-receptor (c-met) and STAT3 on placental tissues from malformed fetuses.
Trovato M; Grosso M; Vitarelli E; Benvenga S; Trimarchi F; Barresi G
Histol Histopathol; 2002; 17(3):691-8. PubMed ID: 12168776
[TBL] [Abstract][Full Text] [Related]
25. Activation of the c-Met receptor complex in fibroblasts drives invasive cell behavior by signaling through transcription factor STAT3.
Cramer A; Kleiner S; Westermann M; Meissner A; Lange A; Friedrich K
J Cell Biochem; 2005 Jul; 95(4):805-16. PubMed ID: 15838885
[TBL] [Abstract][Full Text] [Related]
26. [Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma].
Wu FS; Zheng SS; Wu LJ; Ding W; Ma ZM; Wang ZM; Teng LS; Zhao WH
Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):603-8. PubMed ID: 16784653
[TBL] [Abstract][Full Text] [Related]
27. Hepatocyte growth factor production by neutrophils infiltrating bronchioloalveolar subtype pulmonary adenocarcinoma: role in tumor progression and death.
Wislez M; Rabbe N; Marchal J; Milleron B; Crestani B; Mayaud C; Antoine M; Soler P; Cadranel J
Cancer Res; 2003 Mar; 63(6):1405-12. PubMed ID: 12649206
[TBL] [Abstract][Full Text] [Related]
28. Difference in patterns of Met expression in papillary thyroid carcinomas and nonneoplastic thyroid tissue.
Fluge Ø ; Haugen DR; Lillehaug JR; Varhaug JE
World J Surg; 2001 May; 25(5):623-31. PubMed ID: 11369990
[TBL] [Abstract][Full Text] [Related]
29. Expression and localization of hepatocyte growth factor and its receptor c-Met in inverted papillomas.
Choi JH; Lee SH; Lee HM; Lee SH; Jung HH; Choi J; Lim HW; Lee SW; Kang SM
Acta Otolaryngol; 2006 Jul; 126(7):724-9. PubMed ID: 16803712
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of hepatocyte growth factor and c-MET expression in patients with diffuse large B-cell lymphoma.
Kawano R; Ohshima K; Karube K; Yamaguchi T; Kohno S; Suzumiya J; Kikuchi M; Tamura K
Br J Haematol; 2004 Nov; 127(3):305-7. PubMed ID: 15491290
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of hepatocyte growth factor and its receptor c-Met in nasal polyps.
Rho HS; Lee SH; Lee HM; Lee SH; Jung HH; Choi J; Park MK; Kang SM
Arch Otolaryngol Head Neck Surg; 2006 Sep; 132(9):985-9. PubMed ID: 16982975
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathological significance of expression of p-c-Jun, TCF4 and beta-Catenin in colorectal tumors.
Takeda K; Kinoshita I; Shimizu Y; Ohba Y; Itoh T; Matsuno Y; Shichinohe T; Dosaka-Akita H
BMC Cancer; 2008 Nov; 8():328. PubMed ID: 18992165
[TBL] [Abstract][Full Text] [Related]
33. Expression of hepatocyte growth factor and c-Met in hypopharyngeal squamous cell carcinoma.
Kim CH; Moon SK; Bae JH; Lee JH; Han JH; Kim K; Choi EC
Acta Otolaryngol; 2006 Jan; 126(1):88-94. PubMed ID: 16308260
[TBL] [Abstract][Full Text] [Related]
34. Immunoreactivity for hepatocyte growth factor/scatter factor and its receptor, met, in human lung carcinomas and malignant mesotheliomas.
Harvey P; Warn A; Newman P; Perry LJ; Ball RY; Warn RM
J Pathol; 1996 Dec; 180(4):389-94. PubMed ID: 9014859
[TBL] [Abstract][Full Text] [Related]
35. Change of E-cadherin by hepatocyte growth factor and effects on the prognosis of hypopharyngeal carcinoma.
Kim CH; Kim J; Kahng H; Choi EC
Ann Surg Oncol; 2007 May; 14(5):1565-74. PubMed ID: 17294073
[TBL] [Abstract][Full Text] [Related]
36. Transcriptional targets of hepatocyte growth factor signaling and Ki-ras oncogene activation in colorectal cancer.
Seiden-Long IM; Brown KR; Shih W; Wigle DA; Radulovich N; Jurisica I; Tsao MS
Oncogene; 2006 Jan; 25(1):91-102. PubMed ID: 16158056
[TBL] [Abstract][Full Text] [Related]
37. Expression of hepatocyte growth factor and its receptor c-met, correlates with severity of pathological injury in experimental alcoholic liver disease.
Lalani el-N; Poulsom R; Stamp G; Fogt F; Thomas P; Nanji AA
Int J Mol Med; 2005 May; 15(5):811-7. PubMed ID: 15806303
[TBL] [Abstract][Full Text] [Related]
38. Expression of Met protein and urokinase-type plasminogen activator receptor (uPA-R) in papillary carcinoma of the thyroid.
Zanetti A; Stoppacciaro A; Marzullo A; Ciabatta M; Fazioli F; Prat M; Comoglio PM; Baroni CD; Ruco LP
J Pathol; 1998 Nov; 186(3):287-91. PubMed ID: 10211118
[TBL] [Abstract][Full Text] [Related]
39. Hepatocyte growth factor; expression, concentration and biological activity in chronic leg ulcers.
Nayeri F; Olsson H; Peterson C; Sundqvist T
J Dermatol Sci; 2005 Feb; 37(2):75-85. PubMed ID: 15659325
[TBL] [Abstract][Full Text] [Related]
40. Expression of hepatocyte growth factor and c-MET in skull base chordoma.
Naka T; Kuester D; Boltze C; Scheil-Bertram S; Samii A; Herold C; Ostertag H; Krueger S; Roessner A
Cancer; 2008 Jan; 112(1):104-10. PubMed ID: 17948912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
